Finding new life for first-line antibiotics

April 23, 2015, Duke University
Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke University. Credit: Duke University Photography

Duke University researchers have identified a single, simple metric to guide antibiotic dosing that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.

A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke, revealed that a regimen based on a pathogen's could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line to clear many resistant infections.

Meredith has already begun lab work to create such a database, and early tests are confirming her model's predictions.

The study appears in PLOS Computational Biology on April 23, 2015.

"Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently," said Meredith. "We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible."

The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the bacteria might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.

"You can think of this as a race between the cells and the antibiotics," said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith's adviser. "Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate."

When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics so that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.

Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith's computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.

"There's already a lot of work being done to determine antibiotic dosing schedules," said You. "But that typically involves building a model based on many complex biological mechanisms. This takes a lot of time, and there are thousands of constantly evolving bacterial strains, making it impossible for researchers to catch up. We're trying to see if this one, easy-to-test metric of recovery time can make a good enough prediction without years of study."

Meredith has already begun laboratory work to answer this question and validate her computational model. She has received 80 well-known antibiotic-resistant bacteria strains from Duke Medicine and is putting her theory to the test.

And the early results are promising.

"Our preliminary data have confirmed many of the clinical aspects of the model's predictions, so we are tremendously excited by those," said Meredith. "If this strategy is successful, it could potentially reintroduce a large number of first-line antibiotics for patient treatment."

Explore further: Scientists must reduce antibiotic use in experiments

More information: "Bacterial Temporal Dynamics Enable Optimal Design of Antibiotic Treatment," Hannah R. Meredith, Allison J. Lopatkin, Deverick J. Anderson, Lingchong You. PLOS Computational Biology, 2015, 11(4): e1004201. DOI: 10.1371/journal.pcbi.1004201

Related Stories

Scientists must reduce antibiotic use in experiments

March 20, 2015
Scientists should reduce antibiotic use in lab experiments - according to a researcher at the University of East Anglia.

Could maple syrup help cut use of antibiotics? (w/ Video)

April 16, 2015
A concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics, according to laboratory experiments by researchers at McGill University.

Predicting antibiotic resistance

December 17, 2014
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By ...

Antibiotic resistance is a gut reaction

December 16, 2014
Scientists from the Institute of Food Research and the University of East Anglia have discovered how certain gut bacteria can protect themselves and others in the gut from antibiotics.

Good bacteria armed with antibiotic resistance protect gut microbiome

June 12, 2014
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal ...

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.